Contenidos del Libro:
PART 1: Animal models
1.- Mouse models in the recognition of tumor antigens
2.- Role of heat shock protein in chaperoning tumor antigens and modulating anti-tumor immunity
PART 2: Human tumor antigens recognized by class I HLA-restricted T cells
3.- WT1 as target for tumor immunotherapy
4.- Human melanoma antigens recognized by CD8+ T cells
5.- Squamous cell and adeno cancer antigens recognized by cytotoxic T lymphocytes
6.- Altered peptide ligands of tumor T-cell epitopes: implications for more effective vaccine therapy in human neoplasia
7.- Ex vivo and in situ detection of tumor-specific T-cell immunity with MHC tetramers
PART 3: Human tumor antigens recognized by class II HLA-restricted T cells
8.- Antigens of the MAGE family recognized by CD4+ T cells
9.- Melanoma antigens recognized by CD4+ T cells
PART 4: Human tumor antigens recognized by antibodies
10.- Human tumor antigens recognized by antibodies (SEREX)
11.- Antibodies to human tumor oncoproteins in cancer patients
12.- Antibody and T-cell responses to the NY-ESO-1 antigen
PART 1: Animal models
1.- Mouse models in the recognition of tumor antigens
2.- Role of heat shock protein in chaperoning tumor antigens and modulating anti-tumor immunity
PART 2: Human tumor antigens recognized by class I HLA-restricted T cells
3.- WT1 as target for tumor immunotherapy
4.- Human melanoma antigens recognized by CD8+ T cells
5.- Squamous cell and adeno cancer antigens recognized by cytotoxic T lymphocytes
6.- Altered peptide ligands of tumor T-cell epitopes: implications for more effective vaccine therapy in human neoplasia
7.- Ex vivo and in situ detection of tumor-specific T-cell immunity with MHC tetramers
PART 3: Human tumor antigens recognized by class II HLA-restricted T cells
8.- Antigens of the MAGE family recognized by CD4+ T cells
9.- Melanoma antigens recognized by CD4+ T cells
PART 4: Human tumor antigens recognized by antibodies
10.- Human tumor antigens recognized by antibodies (SEREX)
11.- Antibodies to human tumor oncoproteins in cancer patients
12.- Antibody and T-cell responses to the NY-ESO-1 antigen

